Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
July 30, 2019
Patent Application Number
15386998
Date Filed
December 21, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
The invention relates to humanized antibodies directed against the human lymphocyte receptor CD28. When used in a monovalent form these antibodies are antagonists, i.e. capable of blocking of the CD28/B7 interaction, without activating CD28.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
